Key result
Increased H-FABP within 6 hours of chest pain onset was a strong independent predictor of 6-month outcomes and demonstrated higher diagnostic sensitivity than troponin.
Why the study?
Does H-FABP measurement improve early diagnosis and prognostication of AMI compared to cTnI and CK-MB in patients with chest pain <6 hours?
Observational (n=165)
Does H-FABP measurement improve early diagnosis and prognostication of AMI compared to cTnI and CK-MB in patients with chest pain <6 hours?
H-FABP is a highly sensitive early biomarker for diagnosing AMI within 6 hours of chest pain onset and provides independent prognostic information at 6 months.
Answers are grounded in this paper and cite their sources.
May aid early AMI evaluation; hypothesis-generating and should not yet change troponin-based practice.
BACKGROUND: Heart-type fatty acid-binding protein (H-FABP) is a cytosolic protein that is released into the bloodstream when the myocardium is injured. The aim was to determine the diagnostic and prognostic value of H-FABP in patients with suspected acute myocardial infarction (AMI) within the first 3-6 hours after the onset of chest pain. METHODS AND RESULTS: A consecutive series of 165 patients with chest pain lasting less than 6 hours were enrolled in a forward observational design in the emergency department.The diagnostic validity of H-FABP was evaluated according to sensitivity, specificity, and predictive values, likelihood ratios, ROC curves, and multivariate logistic regression analyses. The prognostic value of H-FABP at 6 months was checked using survival curves and the multivariate Cox proportional hazards model. The sensitivity of H-FABP was 81% (95% CI: 69.2-92.9). Its area under the ROC curve: 0.729 (95% CI: 0.63-0.83) and negative likelihood ratio (0.38; 95% CI: 0.22-0.65) were significantly better than both troponin (cTnI) and CK-MB, whereas its specificity, 53% (95% CI: 41.1-64.8), was lower than that of the other markers. Increased H-FABP added diagnostic information as it demonstrated independent association with AMI by logistic regression analysis. Increased H-FABP and cTnI were both strong and independent predictors of outcome in the 6-month follow-up (hazard ratio: 2.18; 95% CI: 1.07-4.42; and 2.34; 95% CI: 0.98-5.59, respectively). CONCLUSIONS: H-FABP is, within 6 hours and also within 3 hours, more sensitive than the other markers in the early diagnosis of AMI and it is an independent prediction factor of events within 6 months.
No takes yet. Share an insight, caveat, or question.
Garcia-Valdecasas et al. (2011) conducted an observational in suspected acute myocardial infarction (AMI) (n=165). Heart-type fatty acid-binding protein (H-FABP) vs. troponin (cTnI) and CK-MB was evaluated on outcome in the 6-month follow-up (HR 2.18, 95% CI 1.07-4.42). Increased H-FABP within 6 hours of chest pain onset was a strong independent predictor of 6-month outcomes and demonstrated higher diagnostic sensitivity than troponin.
Synapse has enriched 10 related papers. Consider them for comparative context: